Physician profile
Mark W Newman
NPI 1871767459
$2,155.71
in general payments reported to CMS, 2019-2025
16 companies · $20.42 in 2025
The $20.42 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $557 · 2020: $645 · 2021: $614 · 2022: $217 · 2023: $88.30 · 2024: $14.06 · 2025: $20.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $122.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $1,207.61 | 2019-2022 | |
| Boston Scientific Corporation | $275.93 | 2020-2023 | Rotablator Rotational Atherectomy System Console Kit |
| Scilex Pharmaceuticals INC. | $141.66 | 2019 | |
| Mdd US Operations, LLC | $116.17 | 2019-2020 | |
| Zyla Life Sciences, INC. | $70.29 | 2019-2020 | |
| Azurity Pharmaceuticals, INC. | $65.02 | 2023-2025 | Horizant, Horizant |
| Si-Bone, INC. | $48.19 | 2019-2023 | |
| Collegium Pharmaceutical, INC. | $45.01 | 2022 | |
| Forte Bio-Pharma LLC | $36.21 | 2019 | |
| Assertio Therapeutics, INC. | $35.14 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $29.59 | 2019-2021 | |
| Virtus Pharmaceuticals LLC | $28.03 | 2021 | |
| Vertical Pharmaceuticals, LLC | $18.33 | 2019 | |
| Medtronic USA, INC. | $13.70 | 2020 | |
| Horizon Therapeutics Plc | $13.08 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Newman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.